2️⃣ Major finding:
The vaccine markedly boosts neutralizing antibody responses against the currently dominant variants NB.1.8.1 and XFG.
➡️ Enhanced protection against severe COVID-19 can be expected.
3️⃣ Also noteworthy:
Variant BA.3.2.2 evades antibodies from vaccinated individuals more efficiently than XFG.
⚠️ If BA.3.2.2 begins to spread widely, further vaccine refinement might be needed.